| Article Access Statistics | | | Viewed | 3792 | | | Printed | 129 | | | Emailed | 0 | | | PDF Downloaded | 17 | | | Comments | [Add] | | | Cited by others | 2 | | |
|
Click on image for details.
|
|
 |
| LETTER |
|
|
|
| Year : 2011 | Volume
: 57
| Issue : 3 | Page : 257-258 |
Nonalcoholic fatty liver disease in South India
R Pellicano1, S Fagoonee2
1 Department of Gastroenterology and Hepatology, Molinette Hospital, University of Turin, Turin, Italy
2 Department of Biology, Biochemistry and Genetics, Molecular Biotechnology Center, University of Turin, Turin, Italy
| Date of Web Publication | 22-Sep-2011 |
Correspondence Address:
R Pellicano
Department of Gastroenterology and Hepatology, Molinette Hospital, University of Turin, Turin
Italy
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0022-3859.85227
How to cite this article:
Pellicano R, Fagoonee S. Nonalcoholic fatty liver disease in South India. J Postgrad Med 2011;57:257-8 |
Sir,
Martha et al., in an interesting observational study, investigated the prevalence of impaired glucose tolerance, dyslipidemia, metabolic syndrome (MS) and cardiovascular risk factors in a south Indian population. Among the exclusion criteria, the authors considered the presence of liver failure, cirrhosis, a previous history of viral hepatitis and liver enzyme values twice the upper limits. [1]
Nonalcoholic fatty liver disease (NAFLD), frequently associated to diabetes, impaired glucose tolerance, dyslipidemia, and MS, [2] includes a spectrum of disorders ranging from steatosis that generally follows a benign and nonprogressive clinical course to nonalcoholic steatohepatitis [3] which sometimes progresses to cirrhosis and hepatocellular carcinoma. [4] NAFLD, a leading cause of abnormal liver enzymes, is now considered the hepatic manifestation of MS. [2] This condoition is either discovered incidentally during laboratory examination or workup of hypertension, diabetes or morbid obesity, by abdominal ultrasound and/or liver enzyme dosage in serum. [3] In order to evaluate a more extensive data set, it would be of great interest to have more details about the liver enzyme dosage results among the population included by Martha et al. Furthermore, since the level of liver enzymes is not associated to prognosis, [5] nor to the cause of liver disease, it would be useful to know the reason for exclusion of subjects with liver enzyme values twice the upper limits.
| :: References | |  |
| 1. | Martha S, Ramreddy S, Pantam N. Study of impaired glucose tolerance, dyslipidemia, metabolic syndrome, and cardiovascular risk in a south Indian population. J Postgrad Med 2011;57:4-8. 
[PUBMED]  |
| 2. | Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology 2011;140:124-31.
|
| 3. | Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372-84.
|
| 4. | Kadayifci A. Metabolic syndrome and liver transplantation. Panminerva Med 2009;51:205-13.
|
| 5. | Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas and biliary system: Chronic viral hepatitis. BMJ 2001;322:219-21.
|
| This article has been cited by | | 1 |
Prevalence and associated factors for non-alcoholic fatty liver disease among adults in the South Asian Region: a meta-analysis |
|
| Madunil Anuk Niriella, Dileepa Senajith Ediriweera, Madhuri Yasodha Withanage, Selani Darshika, Shamila Thivanshi De Silva, Hithanadura Janaka de Silva | | The Lancet Regional Health - Southeast Asia. 2023; 15: 100220 | | [Pubmed] | [DOI] | | | 2 |
Non-Alcoholic Fatty Liver Disease in the South Asian Region: A Systematic Review and Meta-Analysis |
|
| Madunil Anuk Niriella, Dileepa Senajith Ediriweera, Madhuri Yasodha Withanage, Selani Darshika, Shamila Thivanshi De Silva, Hithanadura Janaka de Silva | | SSRN Electronic Journal. 2022; | | [Pubmed] | [DOI] | |
|
|
|
|
